Johan Beaurain
Well-Known Member
- Joined
- Jan 20, 2007
- Messages
- 412
- Reaction score
- 1
Aspen lifts interim profit on new products, Aids drugs. Copied form the Cape Times 26/02/2007
VERNON WESSELS
Johannesburg - Aspen Phar-macare's interim profit rose 15 percent as the company sold more Aids drugs and introduced new products, Africa's biggest maker of generic drugs said yesterday.
Net income in the six months to December climbed to R331.7 million, or 93c a share, from R288.5 million, or 82c a year earlier, Aspen said in a statement to the JSE yesterday
Sales jumped 15 percent to R1.94 billion.
Aspen is the biggest supplier of generic anti-Aids drugs, called antiretrovirals, and other medicines to the government.
You can view the original blog online at: http://www.blogmark.co.za/index.php?q=node/5119
For some obscure reason the Mail&Guardian is no longer allowing us to access this blog. Untill it becomes accessible again, please refer to the following article that is available online at: http://www.aras.ab.ca/articles/Beaurain/200608-Beaurain-COSATU.html
VERNON WESSELS
Johannesburg - Aspen Phar-macare's interim profit rose 15 percent as the company sold more Aids drugs and introduced new products, Africa's biggest maker of generic drugs said yesterday.
Net income in the six months to December climbed to R331.7 million, or 93c a share, from R288.5 million, or 82c a year earlier, Aspen said in a statement to the JSE yesterday
Sales jumped 15 percent to R1.94 billion.
Aspen is the biggest supplier of generic anti-Aids drugs, called antiretrovirals, and other medicines to the government.
You can view the original blog online at: http://www.blogmark.co.za/index.php?q=node/5119
For some obscure reason the Mail&Guardian is no longer allowing us to access this blog. Untill it becomes accessible again, please refer to the following article that is available online at: http://www.aras.ab.ca/articles/Beaurain/200608-Beaurain-COSATU.html
Last edited: